Instrument Inactif

Communiqués Thc Therapeutics Inc OTC Bulletin Board

Actions

Véhicules et machines lourdes

Cours en clôture OTC Bulletin Board
- ^USD	-

27/02	THC Therapeutics, Inc. publie ses résultats financiers pour l'exercice clos le 31 juillet 2024	CI
27/02	THC Therapeutics, Inc. : l'auditeur exprime des doutes sur la pérennité de l'entreprise	CI

Communiqués

03/03	THC Therapeutics, Inc. Announces Filing of 10-K and Provides Corporate Update	AQ
27/02	THC Therapeutics : Annual Report for Fiscal Year Ending 07-31, 2024 (Form 10-K)	PU
09/07/25	THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery	AQ
24/06/25	THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies	AQ
13/11/24	THC Therapeutics : Quarterly Report for Quarter Ending April 30, 2024 (Form 10-Q)	PU
22/12/22	THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
25/11/22	THC THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
16/06/22	THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
16/05/22	THC THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	AQ
31/03/22	THC THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operation. (form 10-K)	AQ
04/03/22	THC THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
03/01/22	THC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
08/11/21	THC THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
10/09/21	THC Therapeutics : SECURITIES PURCHASE AGREEMENT (Form 8-K)	PU
10/09/21	THC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ
30/08/21	THC Therapeutics : SHEFFORD CAPITAL MANAGEMENT, LLC (Form 8-K)	PU
30/08/21	THC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
04/08/21	THC Therapeutics : Entry into Material Definitive Agreement (Form 8-K)	PU
04/08/21	THC THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
22/06/21	THC THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ
20/04/21	THC Therapeutics Has Completed the dHydronator® Consumer Model Design with photos	GL
08/04/21	THC Therapeutics Engage Milestone Management Services for Investor Relations	GL
06/04/21	THC THERAPEUTICS, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
29/03/21	THC Therapeutics : Quarterly Report (SEC Filing - 10-Q)	PU
29/03/21	THC THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	AQ